The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women

@article{Lasiuk2007TheEO,
  title={The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women},
  author={Gerri Lasiuk and Kathleen Mary Hegadoren},
  journal={Biological Research For Nursing},
  year={2007},
  volume={9},
  pages={147 - 160}
}
Lifetime prevalence rates of depression are higher in women than men. Because this gender disparity appears after the onset of puberty and declines after menopause, gonadal hormones may play a role in women's increased vulnerability to dysphoric states. Estrogens have powerful effects beyond their role in reproduction. Fluctuations in estrogen occur naturally throughout the reproductive years and can be associated with disruptions in mood. Treatment for depression with exogenous estrogen has… Expand
View on SAGE
ncbi.nlm.nih.gov
57 Citations
Highly Influential Citations
1
Background Citations
27

57 Citations

Citation Type

Citation Type

Role of Estradiol in the Expression of Genes Involved in Serotonin Neurotransmission: Implications for Female Depression
TLDR
Estradiol increases tryptophan hydroxylase-2 and serotonin transporter expression and decreases the expres-sion of serotonin 1A receptor and monoamine oxidase A and B through the interaction with its intracellular receptors. Expand
Comparison of the Effects of Estradiol and Progesterone on Serotonergic Function
TLDR
Targeting of ER beta or G-protein coupled receptor 30 might reveal a strategy to permit beneficial effects of estrogen without its deleterious effect on selective serotonin reuptake inhibitor efficacy. Expand
Sex differences and the role of estrogen in animal models of schizophrenia: Interaction with BDNF
TLDR
It is posited estrogen-BDNF interaction could play a key role in modulating sex-dependent results reported in animal work as well as sex differences in clinical aspects of schizophrenia. Expand
Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates
TLDR
Evidence suggests that ovarian hormones modulate serotonin and noradrenaline neurotransmission, a process that may be associated with underlying pathophysiological processes involved in the emergence of depressive symptoms in biologically predisposed subpopulations. Expand
Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders
  • S. Grover, P. Talwar, +6 authors R. Kukreti
  • Biology, Medicine
  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2010
Variability in the physiological levels of neuroactive estrogens is widely believed to play a role in predisposition to several disorders of the central nervous system. Local biosynthesis of… Expand
Association of sex hormones and sex hormone–binding globulin with depressive symptoms in postmenopausal women: the Multiethnic Study of Atherosclerosis
TLDR
In early postmenopausal women, sex hormones were associated with incident depressive symptoms and when stratified by HT use, results were consistent for HT users but attenuated for HT nonusers. Expand
[Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
TLDR
The data obtained indicate a close interaction between the ovary hormonal and serotonergic systems of the brain in the mechanisms of anxiety and depression. Expand
Temperament and ovarian reproductive hormones in women: Evidence from a study during the entire menstrual cycle
TLDR
Evidence is presented for an association between temperamental traits and woman's fecundity, as indicated by levels of ovarian steroid hormones during the menstrual cycle, linking personality and women's reproductive success through a hormonal pathway. Expand
The importance of norepinephrine in depression
TLDR
Preclinical and clinical evidence suggest disturbances in serotonin (5-HT), norepinephrine (NE), and dopamine (DA) neurotransmission in the central nervous system contribute to depression. Expand
Managing Depression during the Menopausal Transition.
The menopausal transition is associated with both first onset of depression and recurrent depression. Risk factors include vasomotor symptoms, a history of premenstrual dysphoria, postpartum… Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 95 REFERENCES
Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding
TLDR
The purpose of this study was to examine whether binding of [3H]paroxetine to the platelet serotonin transporter or binding of [-H]lysergic acid diethylamide to the Platelet 5-HT2A receptor are influenced by the cyclical changes in circulating estradiol and progesterone that occur during the menstrual cycle. Expand
Estrogen augments serotonergic activity in postmenopausal women
TLDR
It is suggested that decreased serotonergic activity in postmenopausal women might contribute to their vulnerability to affective disorders and estrogen replacement therapy might decrease this vulnerability and might add to the efficacy ofserotonergic antidepressants when warranted. Expand
Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical model
TLDR
It is argued that progestins exert differential effects on endogenous levels of neurosteroids, thereby altering mood, and the possibility that fluctuations in neurosteroid levels are responsible for the effects of oral contraceptives on mood is investigated. Expand
Estrogen–serotonin interactions: implications for affective regulation
TLDR
The effects of estrogen on central serotonin systems in animals and humans as inferred from studies demonstrating the impact of gender, estrus (or menstrual) cycle, or hormone manipulation are summarized. Expand
The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding
  • D. Kendall, G. Stancel, S. Enna
  • Psychology, Medicine
  • The Journal of neuroscience : the official journal of the Society for Neuroscience
  • 1982
TLDR
Castration abolishes the decline in the concentration of 5-HT2, but not beta-adrenergic, receptors brought on by chronic imipramine or iprindole treatment in both male and female rats, suggesting that the interaction between the steroids and antidepressants is mediated through estrogenic, rather than androgenic, receptors. Expand
Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats
TLDR
There is a relationship between estrogen and monoamines (i.e. serotonin, dopamine) in modulating the anxiety-like behaviors in female rats, and measurements of brain monoamines following estrogen treatment revealed decreases in norepinephrine, dopamine and serotonin in all of the brain regions studied, which also lead to an increase in turnover rates. Expand
Estrogen‐related Mood Disorders: Reproductive Life Cycle Factors
TLDR
Results indicate that sudden estrogen withdrawal, fluctuating estrogen, and sustained estrogen deficit are correlated with significant mood disturbance. Expand
Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders
TLDR
The continued appreciation of the neural circuitry mediating affective states and their modulation by neurotransmitter systems should further the understanding of the pathophysiology of affective and anxiety disorders. Expand
To what extent do oral contraceptives influence mood and affect?
TLDR
Compared to non-users, OC users experience less variability in affect across the entire menstrual cycle, and less negative affect during menstruation (i.e. withdrawal bleeding). Expand
The Molecular and Neuroanatomical Basis for Estrogen Effects in the Central Nervous System
TLDR
Two aspects are focused on: first, the cellular and molecular mechanisms by which estrogens produce their diverse effects on the brain; and second, the brain regions and cell types in which estrogen produce their effects, emphasizing new knowledge regarding estrogen actions outside of the hypothalamus and pituitary gland. Expand
...
1
2
3
4
5
...